World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
70
Citations
19991
World Ranking
6934
National Ranking
3196

Richard B. Moss publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Richard B. Moss sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 207 publications — 53rd percentile

53% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Richard B. Moss D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Richard B. Moss sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 70 D-Index — 65th percentile

65% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Richard B. Moss is affiliated with Stanford University in the United States. Their research primarily spans the field of Medicine, with a notable focus on Pulmonary and Respiratory Medicine, Infectious Diseases, and Physiology. Their work also touches on Plant Science and Epidemiology, reflecting a range of interdisciplinary interests.

The scientist has contributed to multiple topics within medical research, including:

  • Cystic Fibrosis Research Advances
  • Antifungal resistance and susceptibility
  • Asthma and respiratory diseases
  • Respiratory and cough-related research
  • Tracheal and airway disorders
  • Interstitial lung diseases and idiopathic pulmonary fibrosis
  • Neonatal respiratory health research

Richard B. Moss has published extensively in several reputable venues. Frequent publication outlets include UNC Libraries, European Respiratory Journal, Journal of Fungi, Journal of Cystic Fibrosis, and Pulmonary Therapy. Their published works reflect ongoing contributions to respiratory medicine and cystic fibrosis research.

Recent papers include:

  • "Revised ISHAM-ABPA working group clinical practice guidelines for diagnosing, classifying and treating allergic bronchopulmonary aspergillosis/mycoses," 2024, European Respiratory Journal
  • "Effect of VX-770 in Persons with Cystic Fibrosis and the G551D-CFTR Mutation," 2020, UNC Libraries
  • "Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation," 2020, UNC Libraries
  • "Mucus plugging, air trapping, and bronchiectasis are important outcome measures in assessing progressive childhood cystic fibrosis lung disease," 2020, Pediatric Pulmonology
  • "Biomarkers for the Diagnosis of Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis: A Systematic Review and Meta-Analysis," 2021, The Journal of Allergy and Clinical Immunology In Practice

They have collaborated frequently with several coauthors, including:

  • Steven M. Rowe
  • Michael W. Konstan
  • Joseph M. Pilewski
  • Moira L. Aitken
  • Gina Hong

Best Publications

  • A CFTR potentiator in patients with cystic fibrosis and the G551D mutation

    Bonnie W. Ramsey;Jane Davies;N. Gerard McElvaney;Elizabeth Tullis

  • Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria

    R. Agarwal;A Chakrabarti;A. Shah;D. Gupta

  • Effect of VX-770 in Persons with Cystic Fibrosis and the G551D-CFTR Mutation

    Frank J. Accurso;Steven M. Rowe;J. P. Clancy;Michael P. Boyle

  • Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis—State of the Art: Cystic Fibrosis Foundation Consensus Conference

    David A. Stevens;Richard B. Moss;Viswanath P. Kurup;Alan P. Knutsen

  • Late Pulmonary Sequelae of Bronchopulmonary Dysplasia

    William H. Northway;Richard B. Moss;Kathryn B. Carlisle;Bruce R. Parker

  • Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation

    J. P. Clancy;Steven M. Rowe;Frank J. Accurso;Moira L. Aitken

  • Fungi and allergic lower respiratory tract diseases

    Alan P. Knutsen;Robert K. Bush;Jeffrey G. Demain;David W. Denning

  • Significant microbiological effect of inhaled tobramycin in young children with cystic fibrosis.

    Ronald L. Gibson;Julia Emerson;Sharon McNamara;Jane L. Burns

  • Repeated adeno-associated virus serotype 2 aerosol-mediated cystic fibrosis transmembrane regulator gene transfer to the lungs of patients with cystic fibrosis: a multicenter, double-blind, placebo-controlled trial.

    Richard B. Moss;David Rodman;L. Terry Spencer;Moira L. Aitken

  • High-dose oral N-acetylcysteine, a glutathione prodrug, modulates inflammation in cystic fibrosis.

    Rabindra Tirouvanziam;Carol K. Conrad;Teodoro Bottiglieri;Leonore A. Herzenberg

  • Assessment of safety and efficacy of long-term treatment with combination lumacaftor and ivacaftor therapy in patients with cystic fibrosis homozygous for the F508del-CFTR mutation (PROGRESS): a phase 3, extension study

    Michael W Konstan;Edward F McKone;Richard B Moss;Gautham Marigowda

  • A phase II, double-blind, randomized, placebo-controlled clinical trial of tgAAVCF using maxillary sinus delivery in patients with cystic fibrosis with antrostomies.

    John A. Wagner;Ilynn B. Nepomuceno;Anna H. Messner;Mary Lynn Moran

  • Repeated aerosolized AAV-CFTR for treatment of cystic fibrosis: a randomized placebo-controlled phase 2B trial.

    Richard B Moss;Carlos Milla;John Colombo;Frank Accurso

  • Absence of the β subunit (cchb1) of the skeletal muscle dihydropyridine receptor alters expression of the α1 subunit and eliminates excitation-contraction coupling

    Ronald G. Gregg;Albee Messing;Caroline Strube;Maryline Beurg

  • Erratum: Allergic bronchopulmonary aspergillosis in cystic fibrosis - State of the art: Cystic Fibrosis Foundation Consensus Conference (Clinical Infectious Diseases (2003) 37:Suppl. 3 (S225-64))

    D. A. Stevens;R. B. Moss;V. P. Kurup;A. P. Knutsen

  • A Phase I Study of Aerosolized Administration of tgAAVCF to Cystic Fibrosis Subjects with Mild Lung Disease

    M.L. Aitken;R.B. Moss;D.A. Waltz;M.E. Dovey

  • Efficient and persistent gene transfer of AAV-CFTR in maxillary sinus

    John A Wagner;Thomas Reynolds;Mary Lynn Moran;Richard B Moss

  • Impact of Pseudomonas and Staphylococcus infection on inflammation and clinical status in young children with cystic fibrosis.

    Scott D. Sagel;Ronald L. Gibson;Julia Emerson;Sharon McNamara

  • Safety and biological efficacy of an adeno-associated virus vector-cystic fibrosis transmembrane regulator (AAV-CFTR) in the cystic fibrosis maxillary sinus.

    John A. Wagner;Anna H. Messner;Mary Lynn Moran;Richard Daifuku

  • Efficacy and safety of ivacaftor in patients with cystic fibrosis who have an Arg117His-CFTR mutation: a double-blind, randomised controlled trial

    Richard B Moss;Patrick A Flume;J Stuart Elborn;Jon Cooke

Frequent Co-Authors

Leonore A. Herzenberg
Leonore A. Herzenberg Stanford University
Bonnie W. Ramsey
Bonnie W. Ramsey University of Washington
Michael W. Konstan
Michael W. Konstan Case Western Reserve University
Jeffrey J. Wine
Jeffrey J. Wine Stanford University
David A. Stevens
David A. Stevens Stanford University
John P. Clancy
John P. Clancy Cystic Fibrosis Foundation
Pamela L. Zeitlin
Pamela L. Zeitlin National Jewish Health
Steven M. Rowe
Steven M. Rowe University of Alabama at Birmingham
John A. Wagner
John A. Wagner Cygnal Therapeutics (United States)
Leonard A. Herzenberg
Leonard A. Herzenberg Stanford University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Richard B. Moss

Trending Scientists

Recently Published Articles